The state of Kansas has joined 42 other states and Puerto Rico in a lawsuit against 20 of the nation's largest generic drug manufacturers, Attorney General Derek Schmidt announced today. The lawsuit claims the companies conspired to artificially inflate and manipulate prices, while reducing competition and restraining trade on more than 100 different generic drugs.

The lawsuit was filed in the U.S. District Court for the District of Connecticut and, according to Schmidt, seeks to recover damages, civil penalties and actions by the court to restore competition to the generic drug market. The complaint is the second multistate lawsuit filed during an ever-expanding investigation into generic drug price fixing. The first lawsuit, filed in 2016 in Pennsylvania, is still pending.

A full copy of the complaint can be viewed here.